Inventor
MICHAEL X. GOVEA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Nprimary
A61NElectrotherapy78%
A61BDiagnosis11%
A61MDevices for introducing media into, or onto, the body11%
PatentTitleYear
12,214,200Sensing reference electrode for percutaneous neuromodulation trials202512,011,604Optical stimulation system with on-demand monitoring and methods of making and using202411,648,399Sensing reference electrode for percutaneous neuromodulation trials202311,426,595Optical stimulation system with on-demand monitoring and methods of making and using202211,304,633System and method for providing glucose control therapy202211,224,743Systems and methods for making and using modular leads for electrical stimulation systems202211,147,967Modulation of aldosterone via adrenal gland stimulation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to BOSTON SCIENT NEUROMODULATION CORP (6)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to BOSTON SCIENT SCIMED INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOSTON SCIENT NEUROMODULATION CORP | 6 | 2021–2025 |
| BOSTON SCIENT SCIMED INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2025 |